Global Antiretroviral Drug Market Growth (Status and Outlook) 2025-2031

December 2025 | 85 pages | ID: G581791E4D5EN
LP Information

Abstracts

According to this study, the global Antiretroviral Drug market size will reach US$ million by 2031.

Tire-derived fuel (TDF) is composed of shredded scrap tires.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Antiretroviral Drug Industry Forecast” looks at past sales and reviews total world Antiretroviral Drug sales in 2024, providing a comprehensive analysis by region and market sector of projected Antiretroviral Drug sales for 2025 through 2031. With Antiretroviral Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antiretroviral Drug industry.

This Insight Report provides a comprehensive analysis of the global Antiretroviral Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Antiretroviral Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Antiretroviral Drug market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antiretroviral Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antiretroviral Drug.

This report presents a comprehensive overview, market shares, and growth opportunities of Antiretroviral Drug market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Multi-Class Drugs Combination
• NRTI
• NNRTI
• Protease Inhibitors
• Other

Segmentation by Application:

• Hospital
• Pharmaceutical Companies
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Gilead Sciences
• ViiV Healthcare
• Bristol-Myer Squibb
• AbbVie
• Boehringer-Ingelheim
• Johnson and Johnson
• Merck
• CIPLA

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Antiretroviral Drug Market Size (2020-2031)
  2.1.2 Antiretroviral Drug Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Antiretroviral Drug by Country/Region (2020, 2024 & 2031)
2.2 Antiretroviral Drug Segment by Type
  2.2.1 Multi-Class Drugs Combination
  2.2.2 NRTI
  2.2.3 NNRTI
  2.2.4 Protease Inhibitors
  2.2.5 Other
2.3 Antiretroviral Drug Market Size by Type
  2.3.1 Antiretroviral Drug Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Antiretroviral Drug Market Size Market Share by Type (2020-2025)
2.4 Antiretroviral Drug Segment by Application
  2.4.1 Hospital
  2.4.2 Pharmaceutical Companies
  2.4.3 Other
2.5 Antiretroviral Drug Market Size by Application
  2.5.1 Antiretroviral Drug Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Antiretroviral Drug Market Size Market Share by Application (2020-2025)

3 ANTIRETROVIRAL DRUG MARKET SIZE BY PLAYER

3.1 Antiretroviral Drug Market Size Market Share by Player
  3.1.1 Global Antiretroviral Drug Revenue by Player (2020-2025)
  3.1.2 Global Antiretroviral Drug Revenue Market Share by Player (2020-2025)
3.2 Global Antiretroviral Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ANTIRETROVIRAL DRUG BY REGION

4.1 Antiretroviral Drug Market Size by Region (2020-2025)
4.2 Global Antiretroviral Drug Annual Revenue by Country/Region (2020-2025)
4.3 Americas Antiretroviral Drug Market Size Growth (2020-2025)
4.4 APAC Antiretroviral Drug Market Size Growth (2020-2025)
4.5 Europe Antiretroviral Drug Market Size Growth (2020-2025)
4.6 Middle East & Africa Antiretroviral Drug Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Antiretroviral Drug Market Size by Country (2020-2025)
5.2 Americas Antiretroviral Drug Market Size by Type (2020-2025)
5.3 Americas Antiretroviral Drug Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Antiretroviral Drug Market Size by Region (2020-2025)
6.2 APAC Antiretroviral Drug Market Size by Type (2020-2025)
6.3 APAC Antiretroviral Drug Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Antiretroviral Drug Market Size by Country (2020-2025)
7.2 Europe Antiretroviral Drug Market Size by Type (2020-2025)
7.3 Europe Antiretroviral Drug Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Antiretroviral Drug by Region (2020-2025)
8.2 Middle East & Africa Antiretroviral Drug Market Size by Type (2020-2025)
8.3 Middle East & Africa Antiretroviral Drug Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL ANTIRETROVIRAL DRUG MARKET FORECAST

10.1 Global Antiretroviral Drug Forecast by Region (2026-2031)
  10.1.1 Global Antiretroviral Drug Forecast by Region (2026-2031)
  10.1.2 Americas Antiretroviral Drug Forecast
  10.1.3 APAC Antiretroviral Drug Forecast
  10.1.4 Europe Antiretroviral Drug Forecast
  10.1.5 Middle East & Africa Antiretroviral Drug Forecast
10.2 Americas Antiretroviral Drug Forecast by Country (2026-2031)
  10.2.1 United States Market Antiretroviral Drug Forecast
  10.2.2 Canada Market Antiretroviral Drug Forecast
  10.2.3 Mexico Market Antiretroviral Drug Forecast
  10.2.4 Brazil Market Antiretroviral Drug Forecast
10.3 APAC Antiretroviral Drug Forecast by Region (2026-2031)
  10.3.1 China Antiretroviral Drug Market Forecast
  10.3.2 Japan Market Antiretroviral Drug Forecast
  10.3.3 Korea Market Antiretroviral Drug Forecast
  10.3.4 Southeast Asia Market Antiretroviral Drug Forecast
  10.3.5 India Market Antiretroviral Drug Forecast
  10.3.6 Australia Market Antiretroviral Drug Forecast
10.4 Europe Antiretroviral Drug Forecast by Country (2026-2031)
  10.4.1 Germany Market Antiretroviral Drug Forecast
  10.4.2 France Market Antiretroviral Drug Forecast
  10.4.3 UK Market Antiretroviral Drug Forecast
  10.4.4 Italy Market Antiretroviral Drug Forecast
  10.4.5 Russia Market Antiretroviral Drug Forecast
10.5 Middle East & Africa Antiretroviral Drug Forecast by Region (2026-2031)
  10.5.1 Egypt Market Antiretroviral Drug Forecast
  10.5.2 South Africa Market Antiretroviral Drug Forecast
  10.5.3 Israel Market Antiretroviral Drug Forecast
  10.5.4 Turkey Market Antiretroviral Drug Forecast
10.6 Global Antiretroviral Drug Forecast by Type (2026-2031)
10.7 Global Antiretroviral Drug Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Antiretroviral Drug Forecast

11 KEY PLAYERS ANALYSIS

11.1 Gilead Sciences
  11.1.1 Gilead Sciences Company Information
  11.1.2 Gilead Sciences Antiretroviral Drug Product Offered
  11.1.3 Gilead Sciences Antiretroviral Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Gilead Sciences Main Business Overview
  11.1.5 Gilead Sciences Latest Developments
11.2 ViiV Healthcare
  11.2.1 ViiV Healthcare Company Information
  11.2.2 ViiV Healthcare Antiretroviral Drug Product Offered
  11.2.3 ViiV Healthcare Antiretroviral Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 ViiV Healthcare Main Business Overview
  11.2.5 ViiV Healthcare Latest Developments
11.3 Bristol-Myer Squibb
  11.3.1 Bristol-Myer Squibb Company Information
  11.3.2 Bristol-Myer Squibb Antiretroviral Drug Product Offered
  11.3.3 Bristol-Myer Squibb Antiretroviral Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Bristol-Myer Squibb Main Business Overview
  11.3.5 Bristol-Myer Squibb Latest Developments
11.4 AbbVie
  11.4.1 AbbVie Company Information
  11.4.2 AbbVie Antiretroviral Drug Product Offered
  11.4.3 AbbVie Antiretroviral Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 AbbVie Main Business Overview
  11.4.5 AbbVie Latest Developments
11.5 Boehringer-Ingelheim
  11.5.1 Boehringer-Ingelheim Company Information
  11.5.2 Boehringer-Ingelheim Antiretroviral Drug Product Offered
  11.5.3 Boehringer-Ingelheim Antiretroviral Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Boehringer-Ingelheim Main Business Overview
  11.5.5 Boehringer-Ingelheim Latest Developments
11.6 Johnson and Johnson
  11.6.1 Johnson and Johnson Company Information
  11.6.2 Johnson and Johnson Antiretroviral Drug Product Offered
  11.6.3 Johnson and Johnson Antiretroviral Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Johnson and Johnson Main Business Overview
  11.6.5 Johnson and Johnson Latest Developments
11.7 Merck
  11.7.1 Merck Company Information
  11.7.2 Merck Antiretroviral Drug Product Offered
  11.7.3 Merck Antiretroviral Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Merck Main Business Overview
  11.7.5 Merck Latest Developments
11.8 CIPLA
  11.8.1 CIPLA Company Information
  11.8.2 CIPLA Antiretroviral Drug Product Offered
  11.8.3 CIPLA Antiretroviral Drug Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 CIPLA Main Business Overview
  11.8.5 CIPLA Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Antiretroviral Drug Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Antiretroviral Drug Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Multi-Class Drugs Combination
Table 4. Major Players of NRTI
Table 5. Major Players of NNRTI
Table 6. Major Players of Protease Inhibitors
Table 7. Major Players of Other
Table 8. Antiretroviral Drug Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Antiretroviral Drug Market Size by Type (2020-2025) & ($ millions)
Table 10. Global Antiretroviral Drug Market Size Market Share by Type (2020-2025)
Table 11. Antiretroviral Drug Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 12. Global Antiretroviral Drug Market Size by Application (2020-2025) & ($ millions)
Table 13. Global Antiretroviral Drug Market Size Market Share by Application (2020-2025)
Table 14. Global Antiretroviral Drug Revenue by Player (2020-2025) & ($ millions)
Table 15. Global Antiretroviral Drug Revenue Market Share by Player (2020-2025)
Table 16. Antiretroviral Drug Key Players Head office and Products Offered
Table 17. Antiretroviral Drug Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Antiretroviral Drug Market Size by Region (2020-2025) & ($ millions)
Table 21. Global Antiretroviral Drug Market Size Market Share by Region (2020-2025)
Table 22. Global Antiretroviral Drug Revenue by Country/Region (2020-2025) & ($ millions)
Table 23. Global Antiretroviral Drug Revenue Market Share by Country/Region (2020-2025)
Table 24. Americas Antiretroviral Drug Market Size by Country (2020-2025) & ($ millions)
Table 25. Americas Antiretroviral Drug Market Size Market Share by Country (2020-2025)
Table 26. Americas Antiretroviral Drug Market Size by Type (2020-2025) & ($ millions)
Table 27. Americas Antiretroviral Drug Market Size Market Share by Type (2020-2025)
Table 28. Americas Antiretroviral Drug Market Size by Application (2020-2025) & ($ millions)
Table 29. Americas Antiretroviral Drug Market Size Market Share by Application (2020-2025)
Table 30. APAC Antiretroviral Drug Market Size by Region (2020-2025) & ($ millions)
Table 31. APAC Antiretroviral Drug Market Size Market Share by Region (2020-2025)
Table 32. APAC Antiretroviral Drug Market Size by Type (2020-2025) & ($ millions)
Table 33. APAC Antiretroviral Drug Market Size by Application (2020-2025) & ($ millions)
Table 34. Europe Antiretroviral Drug Market Size by Country (2020-2025) & ($ millions)
Table 35. Europe Antiretroviral Drug Market Size Market Share by Country (2020-2025)
Table 36. Europe Antiretroviral Drug Market Size by Type (2020-2025) & ($ millions)
Table 37. Europe Antiretroviral Drug Market Size by Application (2020-2025) & ($ millions)
Table 38. Middle East & Africa Antiretroviral Drug Market Size by Region (2020-2025) & ($ millions)
Table 39. Middle East & Africa Antiretroviral Drug Market Size by Type (2020-2025) & ($ millions)
Table 40. Middle East & Africa Antiretroviral Drug Market Size by Application (2020-2025) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Antiretroviral Drug
Table 42. Key Market Challenges & Risks of Antiretroviral Drug
Table 43. Key Industry Trends of Antiretroviral Drug
Table 44. Global Antiretroviral Drug Market Size Forecast by Region (2026-2031) & ($ millions)
Table 45. Global Antiretroviral Drug Market Size Market Share Forecast by Region (2026-2031)
Table 46. Global Antiretroviral Drug Market Size Forecast by Type (2026-2031) & ($ millions)
Table 47. Global Antiretroviral Drug Market Size Forecast by Application (2026-2031) & ($ millions)
Table 48. Gilead Sciences Details, Company Type, Antiretroviral Drug Area Served and Its Competitors
Table 49. Gilead Sciences Antiretroviral Drug Product Offered
Table 50. Gilead Sciences Antiretroviral Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 51. Gilead Sciences Main Business
Table 52. Gilead Sciences Latest Developments
Table 53. ViiV Healthcare Details, Company Type, Antiretroviral Drug Area Served and Its Competitors
Table 54. ViiV Healthcare Antiretroviral Drug Product Offered
Table 55. ViiV Healthcare Antiretroviral Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 56. ViiV Healthcare Main Business
Table 57. ViiV Healthcare Latest Developments
Table 58. Bristol-Myer Squibb Details, Company Type, Antiretroviral Drug Area Served and Its Competitors
Table 59. Bristol-Myer Squibb Antiretroviral Drug Product Offered
Table 60. Bristol-Myer Squibb Antiretroviral Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 61. Bristol-Myer Squibb Main Business
Table 62. Bristol-Myer Squibb Latest Developments
Table 63. AbbVie Details, Company Type, Antiretroviral Drug Area Served and Its Competitors
Table 64. AbbVie Antiretroviral Drug Product Offered
Table 65. AbbVie Antiretroviral Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 66. AbbVie Main Business
Table 67. AbbVie Latest Developments
Table 68. Boehringer-Ingelheim Details, Company Type, Antiretroviral Drug Area Served and Its Competitors
Table 69. Boehringer-Ingelheim Antiretroviral Drug Product Offered
Table 70. Boehringer-Ingelheim Antiretroviral Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 71. Boehringer-Ingelheim Main Business
Table 72. Boehringer-Ingelheim Latest Developments
Table 73. Johnson and Johnson Details, Company Type, Antiretroviral Drug Area Served and Its Competitors
Table 74. Johnson and Johnson Antiretroviral Drug Product Offered
Table 75. Johnson and Johnson Antiretroviral Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 76. Johnson and Johnson Main Business
Table 77. Johnson and Johnson Latest Developments
Table 78. Merck Details, Company Type, Antiretroviral Drug Area Served and Its Competitors
Table 79. Merck Antiretroviral Drug Product Offered
Table 80. Merck Antiretroviral Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 81. Merck Main Business
Table 82. Merck Latest Developments
Table 83. CIPLA Details, Company Type, Antiretroviral Drug Area Served and Its Competitors
Table 84. CIPLA Antiretroviral Drug Product Offered
Table 85. CIPLA Antiretroviral Drug Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 86. CIPLA Main Business
Table 87. CIPLA Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Antiretroviral Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Antiretroviral Drug Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Antiretroviral Drug Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Antiretroviral Drug Sales Market Share by Country/Region (2024)
Figure 8. Antiretroviral Drug Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Antiretroviral Drug Market Size Market Share by Type in 2024
Figure 10. Antiretroviral Drug in Hospital
Figure 11. Global Antiretroviral Drug Market: Hospital (2020-2025) & ($ millions)
Figure 12. Antiretroviral Drug in Pharmaceutical Companies
Figure 13. Global Antiretroviral Drug Market: Pharmaceutical Companies (2020-2025) & ($ millions)
Figure 14. Antiretroviral Drug in Other
Figure 15. Global Antiretroviral Drug Market: Other (2020-2025) & ($ millions)
Figure 16. Global Antiretroviral Drug Market Size Market Share by Application in 2024
Figure 17. Global Antiretroviral Drug Revenue Market Share by Player in 2024
Figure 18. Global Antiretroviral Drug Market Size Market Share by Region (2020-2025)
Figure 19. Americas Antiretroviral Drug Market Size 2020-2025 ($ millions)
Figure 20. APAC Antiretroviral Drug Market Size 2020-2025 ($ millions)
Figure 21. Europe Antiretroviral Drug Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Antiretroviral Drug Market Size 2020-2025 ($ millions)
Figure 23. Americas Antiretroviral Drug Value Market Share by Country in 2024
Figure 24. United States Antiretroviral Drug Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Antiretroviral Drug Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Antiretroviral Drug Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Antiretroviral Drug Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Antiretroviral Drug Market Size Market Share by Region in 2024
Figure 29. APAC Antiretroviral Drug Market Size Market Share by Type (2020-2025)
Figure 30. APAC Antiretroviral Drug Market Size Market Share by Application (2020-2025)
Figure 31. China Antiretroviral Drug Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Antiretroviral Drug Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Antiretroviral Drug Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Antiretroviral Drug Market Size Growth 2020-2025 ($ millions)
Figure 35. India Antiretroviral Drug Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Antiretroviral Drug Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Antiretroviral Drug Market Size Market Share by Country in 2024
Figure 38. Europe Antiretroviral Drug Market Size Market Share by Type (2020-2025)
Figure 39. Europe Antiretroviral Drug Market Size Market Share by Application (2020-2025)
Figure 40. Germany Antiretroviral Drug Market Size Growth 2020-2025 ($ millions)
Figure 41. France Antiretroviral Drug Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Antiretroviral Drug Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Antiretroviral Drug Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Antiretroviral Drug Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Antiretroviral Drug Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Antiretroviral Drug Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Antiretroviral Drug Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Antiretroviral Drug Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Antiretroviral Drug Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Antiretroviral Drug Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Antiretroviral Drug Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Antiretroviral Drug Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Antiretroviral Drug Market Size 2026-2031 ($ millions)
Figure 54. APAC Antiretroviral Drug Market Size 2026-2031 ($ millions)
Figure 55. Europe Antiretroviral Drug Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Antiretroviral Drug Market Size 2026-2031 ($ millions)
Figure 57. United States Antiretroviral Drug Market Size 2026-2031 ($ millions)
Figure 58. Canada Antiretroviral Drug Market Size 2026-2031 ($ millions)
Figure 59. Mexico Antiretroviral Drug Market Size 2026-2031 ($ millions)
Figure 60. Brazil Antiretroviral Drug Market Size 2026-2031 ($ millions)
Figure 61. China Antiretroviral Drug Market Size 2026-2031 ($ millions)
Figure 62. Japan Antiretroviral Drug Market Size 2026-2031 ($ millions)
Figure 63. Korea Antiretroviral Drug Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Antiretroviral Drug Market Size 2026-2031 ($ millions)
Figure 65. India Antiretroviral Drug Market Size 2026-2031 ($ millions)
Figure 66. Australia Antiretroviral Drug Market Size 2026-2031 ($ millions)
Figure 67. Germany Antiretroviral Drug Market Size 2026-2031 ($ millions)
Figure 68. France Antiretroviral Drug Market Size 2026-2031 ($ millions)
Figure 69. UK Antiretroviral Drug Market Size 2026-2031 ($ millions)
Figure 70. Italy Antiretroviral Drug Market Size 2026-2031 ($ millions)
Figure 71. Russia Antiretroviral Drug Market Size 2026-2031 ($ millions)
Figure 72. Egypt Antiretroviral Drug Market Size 2026-2031 ($ millions)
Figure 73. South Africa Antiretroviral Drug Market Size 2026-2031 ($ millions)
Figure 74. Israel Antiretroviral Drug Market Size 2026-2031 ($ millions)
Figure 75. Turkey Antiretroviral Drug Market Size 2026-2031 ($ millions)
Figure 76. Global Antiretroviral Drug Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Antiretroviral Drug Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Antiretroviral Drug Market Size 2026-2031 ($ millions)